Loading…

Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease

We evaluated the association between kidney dysfunction and sudden cardiac death risk among ambulatory women with coronary heart disease. The Heart and Estrogen Replacement Study evaluated the effects of hormone treatment on cardiovascular events among 2763 postmenopausal women with coronary heart d...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2008-06, Vol.51 (6), p.1578-1582
Main Authors: Deo, Rajat, Lin, Feng, Vittinghoff, Eric, Tseng, Zian H, Hulley, Stephen B, Shlipak, Michael G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5179-98f76d314264c2809eb96fd5418920ea2fca4613f5607f3a58005bc579af3be53
cites cdi_FETCH-LOGICAL-c5179-98f76d314264c2809eb96fd5418920ea2fca4613f5607f3a58005bc579af3be53
container_end_page 1582
container_issue 6
container_start_page 1578
container_title Hypertension (Dallas, Tex. 1979)
container_volume 51
creator Deo, Rajat
Lin, Feng
Vittinghoff, Eric
Tseng, Zian H
Hulley, Stephen B
Shlipak, Michael G
description We evaluated the association between kidney dysfunction and sudden cardiac death risk among ambulatory women with coronary heart disease. The Heart and Estrogen Replacement Study evaluated the effects of hormone treatment on cardiovascular events among 2763 postmenopausal women with coronary heart disease. Kidney dysfunction was categorized by estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease equation. Multivariate proportional hazards models were used to adjust for cardiovascular risk factors, congestive heart failure, and myocardial infarction. At baseline, 37% (n=1027) had an eGFR of >60 mL/min, 54% (n=1503) had an eGFR of 40 to 60 mL/min, and 8% (n=230) had an eGFR of 60; 0.6% per year with an eGFR between 40 and 60; and 1.7% per year with an eGFR
doi_str_mv 10.1161/HYPERTENSIONAHA.107.103804
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70734346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19724365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5179-98f76d314264c2809eb96fd5418920ea2fca4613f5607f3a58005bc579af3be53</originalsourceid><addsrcrecordid>eNqFkF1rFDEUhoModq3-BQmC3k09-Z54t-yu3WJpxa1Ur4ZsJnFHZ5KazFD23zdlFwVvDBxC3jznhDwIvSFwRogk79ffP6--3KyuNhfXV_P1_IyAKsVq4E_QjAjKKy4ke4pmQDSvNCHfTtCLnH8CEM65eo5OSM1KDGyGNp-6Nrg9Xu6zn4IduxiwCS3eTG3rAl6Y1HbG4qUz4w7Phxh-4Ns4lJvbrgSLmGIwaY_XzqQRL7vsTHYv0TNv-uxeHfdT9PXj6maxri6vzy8W88vKCqJ0pWuvZMsIp5JbWoN2Wy19KzipNQVnqLeGS8K8kKA8M6IGEFsrlDaebZ1gp-jdYe5dir8nl8dm6LJ1fW-Ci1NuFCjGGZf_BYlWlDP5OPHDAbQp5pycb-5SN5QPNgSaR_fNP-5LrpqD-9L8-vjKtB1c-7f1KLsAb4-Aydb0Pplgu_yHo8A0I5QWjh-4-9iPLuVf_XTvUrNzph93DZRVlNUVBahBllNVimr2AGAcnKc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19724365</pqid></control><display><type>article</type><title>Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Deo, Rajat ; Lin, Feng ; Vittinghoff, Eric ; Tseng, Zian H ; Hulley, Stephen B ; Shlipak, Michael G</creator><creatorcontrib>Deo, Rajat ; Lin, Feng ; Vittinghoff, Eric ; Tseng, Zian H ; Hulley, Stephen B ; Shlipak, Michael G</creatorcontrib><description>We evaluated the association between kidney dysfunction and sudden cardiac death risk among ambulatory women with coronary heart disease. The Heart and Estrogen Replacement Study evaluated the effects of hormone treatment on cardiovascular events among 2763 postmenopausal women with coronary heart disease. Kidney dysfunction was categorized by estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease equation. Multivariate proportional hazards models were used to adjust for cardiovascular risk factors, congestive heart failure, and myocardial infarction. At baseline, 37% (n=1027) had an eGFR of &gt;60 mL/min, 54% (n=1503) had an eGFR of 40 to 60 mL/min, and 8% (n=230) had an eGFR of &lt;40 mL/min. During the 6.8-year follow-up period, there were 136 adjudicated sudden cardiac deaths. The rate of sudden cardiac death was higher in those with lower kidney function (0.5% per year among those with an eGFR &gt;60; 0.6% per year with an eGFR between 40 and 60; and 1.7% per year with an eGFR &lt;40 mL/min; P for trend &lt;0.001). After multivariate analysis with baseline risk factors, eGFR at 40 to 60 mL/min was not a significant predictor, but eGFR at &lt;40 mL/min remained strongly associated with sudden cardiac death (hazard ratio3.2; 95% CI1.9 to 5.3); adjustment for incident congestive heart failure and myocardial infarction during follow-up diminished this association (hazard ratio2.3; 95% CI1.3 to 3.9), suggesting that congestive heart failure and myocardial infarction mediated only part of the association between kidney dysfunction and sudden cardiac death. Advanced kidney dysfunction is an independent predictor of sudden cardiac death among women with coronary heart disease.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.107.103804</identifier><identifier>PMID: 18391103</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Aged ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Coronary Disease - mortality ; Coronary Disease - prevention &amp; control ; Coronary heart disease ; Death, Sudden, Cardiac - epidemiology ; Estrogen Replacement Therapy ; Estrogens, Conjugated (USP) - administration &amp; dosage ; Female ; Follow-Up Studies ; Glomerular Filtration Rate ; Heart ; Humans ; Incidence ; Kidney Diseases - mortality ; Medical sciences ; Medroxyprogesterone Acetate - administration &amp; dosage ; Middle Aged ; Multivariate Analysis ; Postmenopause ; Predictive Value of Tests ; Risk Factors</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2008-06, Vol.51 (6), p.1578-1582</ispartof><rights>2008 American Heart Association, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5179-98f76d314264c2809eb96fd5418920ea2fca4613f5607f3a58005bc579af3be53</citedby><cites>FETCH-LOGICAL-c5179-98f76d314264c2809eb96fd5418920ea2fca4613f5607f3a58005bc579af3be53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20393122$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18391103$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deo, Rajat</creatorcontrib><creatorcontrib>Lin, Feng</creatorcontrib><creatorcontrib>Vittinghoff, Eric</creatorcontrib><creatorcontrib>Tseng, Zian H</creatorcontrib><creatorcontrib>Hulley, Stephen B</creatorcontrib><creatorcontrib>Shlipak, Michael G</creatorcontrib><title>Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>We evaluated the association between kidney dysfunction and sudden cardiac death risk among ambulatory women with coronary heart disease. The Heart and Estrogen Replacement Study evaluated the effects of hormone treatment on cardiovascular events among 2763 postmenopausal women with coronary heart disease. Kidney dysfunction was categorized by estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease equation. Multivariate proportional hazards models were used to adjust for cardiovascular risk factors, congestive heart failure, and myocardial infarction. At baseline, 37% (n=1027) had an eGFR of &gt;60 mL/min, 54% (n=1503) had an eGFR of 40 to 60 mL/min, and 8% (n=230) had an eGFR of &lt;40 mL/min. During the 6.8-year follow-up period, there were 136 adjudicated sudden cardiac deaths. The rate of sudden cardiac death was higher in those with lower kidney function (0.5% per year among those with an eGFR &gt;60; 0.6% per year with an eGFR between 40 and 60; and 1.7% per year with an eGFR &lt;40 mL/min; P for trend &lt;0.001). After multivariate analysis with baseline risk factors, eGFR at 40 to 60 mL/min was not a significant predictor, but eGFR at &lt;40 mL/min remained strongly associated with sudden cardiac death (hazard ratio3.2; 95% CI1.9 to 5.3); adjustment for incident congestive heart failure and myocardial infarction during follow-up diminished this association (hazard ratio2.3; 95% CI1.3 to 3.9), suggesting that congestive heart failure and myocardial infarction mediated only part of the association between kidney dysfunction and sudden cardiac death. Advanced kidney dysfunction is an independent predictor of sudden cardiac death among women with coronary heart disease.</description><subject>Aged</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Coronary Disease - mortality</subject><subject>Coronary Disease - prevention &amp; control</subject><subject>Coronary heart disease</subject><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>Estrogen Replacement Therapy</subject><subject>Estrogens, Conjugated (USP) - administration &amp; dosage</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glomerular Filtration Rate</subject><subject>Heart</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kidney Diseases - mortality</subject><subject>Medical sciences</subject><subject>Medroxyprogesterone Acetate - administration &amp; dosage</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Postmenopause</subject><subject>Predictive Value of Tests</subject><subject>Risk Factors</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkF1rFDEUhoModq3-BQmC3k09-Z54t-yu3WJpxa1Ur4ZsJnFHZ5KazFD23zdlFwVvDBxC3jznhDwIvSFwRogk79ffP6--3KyuNhfXV_P1_IyAKsVq4E_QjAjKKy4ke4pmQDSvNCHfTtCLnH8CEM65eo5OSM1KDGyGNp-6Nrg9Xu6zn4IduxiwCS3eTG3rAl6Y1HbG4qUz4w7Phxh-4Ns4lJvbrgSLmGIwaY_XzqQRL7vsTHYv0TNv-uxeHfdT9PXj6maxri6vzy8W88vKCqJ0pWuvZMsIp5JbWoN2Wy19KzipNQVnqLeGS8K8kKA8M6IGEFsrlDaebZ1gp-jdYe5dir8nl8dm6LJ1fW-Ci1NuFCjGGZf_BYlWlDP5OPHDAbQp5pycb-5SN5QPNgSaR_fNP-5LrpqD-9L8-vjKtB1c-7f1KLsAb4-Aydb0Pplgu_yHo8A0I5QWjh-4-9iPLuVf_XTvUrNzph93DZRVlNUVBahBllNVimr2AGAcnKc</recordid><startdate>200806</startdate><enddate>200806</enddate><creator>Deo, Rajat</creator><creator>Lin, Feng</creator><creator>Vittinghoff, Eric</creator><creator>Tseng, Zian H</creator><creator>Hulley, Stephen B</creator><creator>Shlipak, Michael G</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200806</creationdate><title>Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease</title><author>Deo, Rajat ; Lin, Feng ; Vittinghoff, Eric ; Tseng, Zian H ; Hulley, Stephen B ; Shlipak, Michael G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5179-98f76d314264c2809eb96fd5418920ea2fca4613f5607f3a58005bc579af3be53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Coronary Disease - mortality</topic><topic>Coronary Disease - prevention &amp; control</topic><topic>Coronary heart disease</topic><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>Estrogen Replacement Therapy</topic><topic>Estrogens, Conjugated (USP) - administration &amp; dosage</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glomerular Filtration Rate</topic><topic>Heart</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kidney Diseases - mortality</topic><topic>Medical sciences</topic><topic>Medroxyprogesterone Acetate - administration &amp; dosage</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Postmenopause</topic><topic>Predictive Value of Tests</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deo, Rajat</creatorcontrib><creatorcontrib>Lin, Feng</creatorcontrib><creatorcontrib>Vittinghoff, Eric</creatorcontrib><creatorcontrib>Tseng, Zian H</creatorcontrib><creatorcontrib>Hulley, Stephen B</creatorcontrib><creatorcontrib>Shlipak, Michael G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deo, Rajat</au><au>Lin, Feng</au><au>Vittinghoff, Eric</au><au>Tseng, Zian H</au><au>Hulley, Stephen B</au><au>Shlipak, Michael G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2008-06</date><risdate>2008</risdate><volume>51</volume><issue>6</issue><spage>1578</spage><epage>1582</epage><pages>1578-1582</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>We evaluated the association between kidney dysfunction and sudden cardiac death risk among ambulatory women with coronary heart disease. The Heart and Estrogen Replacement Study evaluated the effects of hormone treatment on cardiovascular events among 2763 postmenopausal women with coronary heart disease. Kidney dysfunction was categorized by estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease equation. Multivariate proportional hazards models were used to adjust for cardiovascular risk factors, congestive heart failure, and myocardial infarction. At baseline, 37% (n=1027) had an eGFR of &gt;60 mL/min, 54% (n=1503) had an eGFR of 40 to 60 mL/min, and 8% (n=230) had an eGFR of &lt;40 mL/min. During the 6.8-year follow-up period, there were 136 adjudicated sudden cardiac deaths. The rate of sudden cardiac death was higher in those with lower kidney function (0.5% per year among those with an eGFR &gt;60; 0.6% per year with an eGFR between 40 and 60; and 1.7% per year with an eGFR &lt;40 mL/min; P for trend &lt;0.001). After multivariate analysis with baseline risk factors, eGFR at 40 to 60 mL/min was not a significant predictor, but eGFR at &lt;40 mL/min remained strongly associated with sudden cardiac death (hazard ratio3.2; 95% CI1.9 to 5.3); adjustment for incident congestive heart failure and myocardial infarction during follow-up diminished this association (hazard ratio2.3; 95% CI1.3 to 3.9), suggesting that congestive heart failure and myocardial infarction mediated only part of the association between kidney dysfunction and sudden cardiac death. Advanced kidney dysfunction is an independent predictor of sudden cardiac death among women with coronary heart disease.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>18391103</pmid><doi>10.1161/HYPERTENSIONAHA.107.103804</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2008-06, Vol.51 (6), p.1578-1582
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_70734346
source Free E-Journal (出版社公開部分のみ)
subjects Aged
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Coronary Disease - mortality
Coronary Disease - prevention & control
Coronary heart disease
Death, Sudden, Cardiac - epidemiology
Estrogen Replacement Therapy
Estrogens, Conjugated (USP) - administration & dosage
Female
Follow-Up Studies
Glomerular Filtration Rate
Heart
Humans
Incidence
Kidney Diseases - mortality
Medical sciences
Medroxyprogesterone Acetate - administration & dosage
Middle Aged
Multivariate Analysis
Postmenopause
Predictive Value of Tests
Risk Factors
title Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A48%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kidney%20Dysfunction%20and%20Sudden%20Cardiac%20Death%20Among%20Women%20With%20Coronary%20Heart%20Disease&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Deo,%20Rajat&rft.date=2008-06&rft.volume=51&rft.issue=6&rft.spage=1578&rft.epage=1582&rft.pages=1578-1582&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/HYPERTENSIONAHA.107.103804&rft_dat=%3Cproquest_cross%3E19724365%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5179-98f76d314264c2809eb96fd5418920ea2fca4613f5607f3a58005bc579af3be53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19724365&rft_id=info:pmid/18391103&rfr_iscdi=true